Provided by Tiger Fintech (Singapore) Pte. Ltd.

SILO PHARMA INC.

0.7709
-0.0391-4.83%
Volume:489.54K
Turnover:385.46K
Market Cap:3.46M
PE:-0.65
High:0.8000
Open:0.7700
Low:0.7644
Close:0.8100
Loading ...

BRIEF-Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints In Fibromyalgia Study

Reuters
·
1 hour ago

Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia Study

THOMSON REUTERS
·
1 hour ago

Silo Pharma Inc - No Implant-Related Adverse Events Observed in Study

THOMSON REUTERS
·
1 hour ago

BRIEF-Silo Pharma Expands Intellectual Property Portfolio With Patent Application For Exclusively Licensed Alzheimer’S Drug

Reuters
·
28 Apr

Silo Pharma files patent application with USPTO for SPC-14

TIPRANKS
·
28 Apr

Silo Pharma Expands Intellectual Property Portfolio With Patent Application for Exclusively Licensed Alzheimer’s Drug

THOMSON REUTERS
·
28 Apr

Psychedelic: Clearmind completes clinical site initiations for AUD trial

TipRanks
·
25 Apr

Saucony® Unveils Saucony SILO: A New Pinnacle in Luxury Footwear

PR Newswire
·
17 Apr

Silo Pharma announces first dosing in IND-enabling study for SPC-15

TIPRANKS
·
26 Mar

BRIEF-Silo Pharma Achieves Key Milestone With First Dosing In IND-Enabling GLP Study For SPC-15 As A Groundbreaking PTSD Treatment

Reuters
·
26 Mar

Silo Pharma Achieves Key Milestone with First Dosing in IND-Enabling GLP Study for SPC-15 as a Groundbreaking PTSD Treatment

GlobeNewswire
·
26 Mar

Psychedelic: Exclusive talk with biotech company Clearmind Medicine

TipRanks
·
22 Mar

Psychedelic: atai reports dosing of first patient in Phase 2 VLS-01 trial

TipRanks
·
14 Mar

Silo Pharma Granted US Patent for Intranasal Post-Traumatic Stress Disorder Treatment

MT Newswires Live
·
27 Feb

BRIEF-Silo Pharma Expands Intellectual Property Portfolio With Provisional Patent Filing For Innovative SPC-15 Combination Treatment

Reuters
·
18 Feb

Silo Pharma files provisional patent for SPC-15 combination

TIPRANKS
·
18 Feb

Silo Pharma Expands Intellectual Property Portfolio With Provisional Patent Filing for Innovative Spc-15 Combination Treatment

THOMSON REUTERS
·
18 Feb

Silo Pharma Expands Intellectual Property Portfolio with Provisional Patent Filing for Innovative SPC-15 Combination Treatment

GlobeNewswire
·
18 Feb

BRIEF-Silo Pharma Announces Positive Initial Pharmacokinetic, Safety, And Tolerability Study Of SP-26 For Chronic Pain And Fibromyalgia

Reuters
·
11 Feb

Silo Pharma Inc - Final Safety and Absorption Data Expected in March 2025

THOMSON REUTERS
·
11 Feb